03 Feb R3 Medical Training Opens Enrollment for Hands On Aesthetics Course with Botox, PRP, Fillers and Exosomes
R3 Medical Training has opened enrollment for its hands-on Regenerative Aesthetics Course for April 9-10th, 2022, in San Diego CA. The Aesthetics Course teaches Botox, Dysport, Fillers, PRP, Exosomes, and PDO Threads in a hands-on setting with real procedures on real patients.
Our trainers teach how to evaluate patients and plan procedures, but the main reason our attendees rave about the experience is how much hands-on experience is included!”
— David Greene, MD, Ph.D., MBA
Attendees love the experiential learning environment, where the philosophy is to “see one, do one, and have one.” In fact, attendees get lots of experience performing procedures under expert trainer guidance, which embeds the skill set necessary to immediately start performing them in practice.
According to R3 CEO David Greene, MD, Ph.D., MBA, “Our trainers teach how to evaluate patients and plan procedures, but the main reason our attendees rave about the experience is how much hands-on experience is included! We don’t use cadavers or animal meat for procedures, but actual patients who are excited about working with R3’s courses.”
Procedures are taught on facial rejuvenation, hair restoration, and sexual dysfunction. Attendees learn topical techniques, micro needling, and injection procedures for each area. In addition, attendees are provided online access for all the handouts and videos for continued learning afterward.
Patients ask now about the latest aesthetics procedures including exosomes, PRP, and thread lifts. This course teaches how to evaluate patients and make the decision of what procedures to incorporate for the best outcomes performed in the safest manner.
The day prior to the course, R3 is offering a PDO Thread Lift Certification Course. Providers need to be Certified in order to perform the cosmetic thread procedures.
To learn more about the courses and sign up, visit https://r3medicaltraining.com or call (888) 998-6343.
David Greene, MD, Ph.D., MBA
R3 Medical Training
+1 888-998-6343
ABOUT US
The information provided by R3 Stem Cell is not a substitute for professional medical advice, diagnosis, or treatment. Individual results may vary and only your medical professional can explain all the risks and potential benefits of any therapy based on your circumstances. R3 Stem Cell does not recommend or endorse any specific tests, products, procedures, opinions, or other information that may be mentioned on this website. Reliance on any information provided by R3 Stem Cell, its employees, others appearing on this website at the invitation of R3 Stem Cell, or other visitors to the website is solely at your own risk. R3 Stem Cell is not responsible for the outcome of your procedure. The FDA considers stem cell therapy experimental at this point.
Recent R3 Stem Cell Awards & Accolades
CALIFORNIA
- San Diego
- San Jose
- Fresno
- Anaheim
- Bakersfield
- Beverly Hills
- Chula Vista
- Corona
- Elk Grove
- Escondido
- Fremont
- Fontana
- Fullerton
- Hayward
- Huntington Beach
- Garden Grove
- Irvine
- Sacramento
- Lancaster
- Long Beach
- Los Angeles
- Los Angeles Regenerative Medicine
- Modesto
- Moreno Valley
- Oakland
- Oceanside
- Ontario
- Orange
- Oxnard
- Palmdale
- Pomona
- Rancho Cucamonga
- Riverside
- Roseville
- Salinas
- San Bernardino
- Santa Ana
- Santa Clarita
- Santa Rosa
- Stockton
- Sunnyvale
- Torrance
FLORIDA
- Jacksonville
- Cape Coral
- Fort Lauderdale
- Hialeah
- Hollywood
- Miami
- Miramar
- Orlando
- Pembroke Pines
- Port St. Lucie
- St. Petersburg
- Tallahassee
- Tampa
GEORGIA
HAWAII
IDAHO
ILLINOIS
INDIANA
IOWA
KANSAS
KENTUCKY
LOUISIANA
MARYLAND
MASSACHUSETTS
MICHIGAN
MINNESOTA
MISSISSIPPI
MISSOURI
NEBRASKA
NEW JERSEY
NEW YORK
NEW MEXICO
NEVADA
NORTH CAROLINA
OHIO
OKLAHOMA
OREGON
PENNSYLVANIA
RHODE ISLAND
SOUTH CAROLINA
SOUTH DAKOTA
TENNESSEE
The USA stem cell leader offers procedures in
7 Countries including:
Copyright © 2017-2024 R3 Stem Cell. All Rights Reserved.
Sorry, the comment form is closed at this time.